Confluence Wealth Services Inc. Increases Stock Position in Teleflex Incorporated (NYSE:TFX)

Confluence Wealth Services Inc. grew its stake in shares of Teleflex Incorporated (NYSE:TFX) by 39.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,410 shares of the medical technology company’s stock after buying an additional 400 shares during the period. Confluence Wealth Services Inc.’s holdings in Teleflex were worth $255,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Cromwell Holdings LLC grew its stake in shares of Teleflex by 59.0% during the 3rd quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock valued at $33,000 after buying an additional 49 shares during the period. Avior Wealth Management LLC lifted its holdings in shares of Teleflex by 190.6% during the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock valued at $38,000 after acquiring an additional 101 shares in the last quarter. Ashton Thomas Securities LLC acquired a new position in shares of Teleflex during the 3rd quarter valued at $40,000. True Wealth Design LLC lifted its holdings in shares of Teleflex by 16,600.0% during the 3rd quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock valued at $41,000 after acquiring an additional 166 shares in the last quarter. Finally, GAMMA Investing LLC lifted its holdings in shares of Teleflex by 131.1% during the 3rd quarter. GAMMA Investing LLC now owns 171 shares of the medical technology company’s stock valued at $42,000 after acquiring an additional 97 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Stock Performance

Shares of TFX stock opened at $173.61 on Friday. Teleflex Incorporated has a 12 month low of $171.69 and a 12 month high of $256.85. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The firm has a market capitalization of $8.06 billion, a P/E ratio of 34.51, a P/E/G ratio of 1.78 and a beta of 1.16. The company’s fifty day moving average price is $180.84 and its two-hundred day moving average price is $211.88.

Analyst Ratings Changes

TFX has been the topic of several recent research reports. Royal Bank of Canada reduced their target price on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Mizuho reduced their target price on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, November 1st. Finally, Truist Financial reduced their target price on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a report on Wednesday, December 18th. Three analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $252.50.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.